<bill session="117" type="h" number="5270" updated="2022-12-31T08:59:33Z">
  <state datetime="2021-09-17">REFERRED</state>
  <status>
    <introduced datetime="2021-09-17"/>
  </status>
  <introduced datetime="2021-09-17"/>
  <titles>
    <title type="official" as="introduced">To prohibit the National Institutes of Health from conducting or supporting certain gain-of-function research, and for other purposes.</title>
    <title type="display">Pausing Enhanced Pandemic Pathogen Research Act of 2021</title>
    <title type="short" as="introduced">Pausing Enhanced Pandemic Pathogen Research Act of 2021</title>
  </titles>
  <sponsor bioguide_id="C001103"/>
  <cosponsors>
    <cosponsor bioguide_id="C001063" joined="2021-09-17"/>
    <cosponsor bioguide_id="G000579" joined="2021-09-17"/>
  </cosponsors>
  <actions>
    <action datetime="2021-09-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-09-17" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-09-20">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Genetics"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2022-02-07T18:57:29Z" status="Introduced in House">Pausing Enhanced Pandemic Pathogen Research Act of 2021

This bill temporarily prohibits the National Institutes of Health from conducting or supporting research on any influenza virus or coronavirus if the research is reasonably expected to increase the virus's pathogenicity or transmissibility in mammals via the respiratory route.</summary>
</bill>
